PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
From:
Cancer Res. Author manuscript; available in PMC 2010 April 1.
Published in final edited form as:
Cancer Res. 2009 April 1; 69(7): 2801–2808.
Published online 2009 March 24. doi: 10.1158/0008-5472.CAN-08-4051

Figure 1

An external file that holds a picture, illustration, etc.
Object name is nihms95505f1.jpg
eNOS activity and NO-induced proliferation of lymphatic endothelial cells

(A) VEGF-C and VEGF-C (C156S) induce PI3K-dependent activation of eNOS in LECs. Signaling through VEGFR-2 and VEGFR-3 leads to activation of eNOS, Akt and p42/p44 in LECs as detected by Western blot analysis for phosphorylated eNOS (Ser1177), Akt (473) and p42/p44 (Thr202/Tyr204) proteins after LEC stimulation with VEGF-A, VEGF-C and VEGF-C (C156S). eNOS activation after VEGFR-2 or VEGFR-3 stimulation is dependent on PI3K activity as shown by decreased eNOS phosphorylation after pretreatment of LECs with PI3K inhibitor Wortmannin. (B) Effect of exogenous NO donors on lymphatic endothelial cell proliferation and/or survival. LEC proliferation and/or survival in response to increasing concentrations of NO donors DETA-NONOate and Glyco-SNAP-2 in growth factor reduced media was analyzed after 72h treatment using WST-1 cell proliferation reagent. Absorbance (450nm) obtained for cells incubated with full endothelial cell growth media was set to 100%. Bars represent mean ± SEM of quadruplicate samples. *P<0.05, Student t test.

Images in this article

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
Click on the image to see a larger version.